ELAB - CIK 0001840563
The table below shows Elevai Labs Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | - | - | - | - | - | - |
| Short-term investments | $733.40K | $804.07K | $624.84K | $557.38K | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | $253.56K | $128.47K | - | - | $986.42K | $978.55K |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $16.39M |
| $9.77M |
| $7.30M |
| $6.82M |
| $8.23M |
| $2.03M |
| Property, plant & equipment | $1.75M | $413.45K | $1.09K | $1.09K | $52.53K | $55.75K |
| Goodwill | $1.86M | $959.53K | - | - | - | - |
| Total assets | $26.03M | $14.94M | $9.38M | $8.89M | $11.21M | $5.08M |
| Accounts payable | - | - | - | - | $1.08M | $1.14M |
| Total current liabilities | $11.30M | $5.46M | $326.30K | $760.27K | $2.13M | $1.94M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $13.43M | $6.45M | $326.30K | $760.27K | $2.65M | $2.44M |
| Retained earnings | -$25.98M | -$18.03M | -$15.44M | -$14.88M | -$11.33M | -$9.83M |
| Total equity | $12.61M | $8.49M | $9.05M | $8.13M | $8.56M | $2.64M |